Pertuzumab beim HER2-positiven metastasierten Mammakarzinom in der Routinebehandlung – Daten aus dem Tumorregister Mammakarzinom. 29. Juli 2019 Overkamp, F; Frühauf, S; Fietz, T; Behringer, J; Kruggel, L; Wetzel, N; Marschner, N, 2019. Senologie 2019; 16(02): 31 – 31 DOI: 10.1055/s-0039-1688031 Abstract Download Sequential treatment with pazopanib (PAZO) followed by nivolumab (NIVO) in patients with advanced or metastatic renal cell carcinoma (mRCC): Third interim results of the non-interventional study PAZOREAL. M Boegemann, J Bedke, M Schostak, C Hering-Schubert, M Welslau, J Schleicher, T Wolf, A Petzoldt, C Doehn, C Grüllich, V Grünwald, T Steiner, A… Weiterlesen Lenalidomide in combination with dexamethasone as first-line therapy in transplant-ineligible patients with Multiple Myeloma: Interim Results of the observational study FIRST-NIS. H. Nückel; H.-J. Hurtz; H. Schulz; M. Schulze; M. Koenigsmann; T. Dechow; M. Merling; L. Houet; C. Vannier; K. Potthoff; 2019. HemaSphere. 3():263–264, JUN… Weiterlesen